Bdo Wealth Advisors, LLC Nymox Pharmaceutical Corp Transaction History

Bdo Wealth Advisors, LLC

$867 Million
Q2 2023

A detailed history of Bdo Wealth Advisors, LLC transactions in Nymox Pharmaceutical Corp stock. As of the latest transaction made, Bdo Wealth Advisors, LLC holds 4,700 shares of NYMX stock, worth $2,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,700

Previous 4,700 -0.0%

Holding current value

$2,209

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 25, 2022	BUY	$0.38 - $1.41 $1,786 - $6,627	4,700 New	4,700 $2,000
Q3 2021 Nov 09, 2021	SELL	$1.3 - $2.23 $6,110 - $10,481	-4,700 Closed	0 $0
Q2 2021 Sep 03, 2021	BUY	$1.46 - $2.48 $6,862 - $11,656	4,700 New	4,700 $7,000
Q3 2020 Nov 12, 2020	SELL	$2.3 - $3.66 $10,810 - $17,202	-4,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.69 - $3.88 $7,943 - $18,236	4,700 New	4,700 $11,000

Others Institutions Holding NYMX

# of Institutions

Shares Held

74.9K

Call Options Held

Put Options Held

View Full List

About NYMOX PHARMACEUTICAL CORP

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

More about NYMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.

Account

Bdo Wealth Advisors, LLC Nymox Pharmaceutical Corp Transaction History